Previous Hold Today IMM.L ranks #3216 as HOLD CANDIDATE. Next Hold
Today IMM.L ranks #3216 as HOLD CANDIDATE.

IMM.L stock Immupharma Plc

IMM.L stock
Immupharma Plc

March 18, 2019
Change 1.09%
Chart period: 2018-12-19 - 2019-03-18
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Will IMM.L stock price go up or down on Wed, 20 Mar 2019?

Immupharma Plc Forecast and Stock Analysis

Technical IMM.L stock analysis for March 18, 2019.

Hold candidate since 2019-03-18

Immupharma Plc gained 1.09% in the last trading day, rising from £11.48 to £11.60 The price has fallen in 6 of the last 10 days and is down by -5.69% for this period. Volume fell in the last day by -30 926 shares, and in total, 582 980 shares bought and sold for approximately £6.76 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Monday, 18th Mar 2019) of the IMM.L stock was £11.60. This is 1.09% more than the trading day before Friday, 15th Mar 2019.

During day the stock fluctuated 4.82% from a day low at £11.40 to a day high of £11.95.

30 day high of the IMM.L stock price was £18.50 and low was £10.20.
90 day high was £18.50 and low was £10.10.
52 week high for the Immupharma Plc - £181.50 and low - £9.06.

Trend

Immupharma Plc lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at £11.00 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.9% during the next 3 months and, with 90% probability hold a price between £11.76 and £19.10 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Friday March 15, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Immupharma Plc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at £11.89 and £12.00. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 40 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Immupharma Plc finds support from accumulated volume at £11.50.

Support: £11.50 Price: £11.60 Resistance: £13.00

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved £0.55 between high and low, or 4.82%. For the last week, the stock has had a daily average volatility of 9.56%.

Our recommended stoploss: £10.83 (-6.67%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Hold/Accumulate

Immupharma Plc holds several negative signals and this should give a sell recommendation, but due to the general chance for a turnaround situation we recommend to hold or accumulate whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Previous Hold Today IMM.L ranks #3216 as HOLD CANDIDATE. Next Hold
Today IMM.L ranks #3216 as HOLD CANDIDATE.